CA1058075A - Process of improving the compatibility of gamma globulins - Google Patents

Process of improving the compatibility of gamma globulins

Info

Publication number
CA1058075A
CA1058075A CA242,734A CA242734A CA1058075A CA 1058075 A CA1058075 A CA 1058075A CA 242734 A CA242734 A CA 242734A CA 1058075 A CA1058075 A CA 1058075A
Authority
CA
Canada
Prior art keywords
gamma globulin
solution
blood
process according
precipitated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA242,734A
Other languages
English (en)
French (fr)
Inventor
Dietrich Wolter
Waldemar Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plasmesco AG
Original Assignee
Plasmesco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasmesco AG filed Critical Plasmesco AG
Application granted granted Critical
Publication of CA1058075A publication Critical patent/CA1058075A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CA242,734A 1975-01-02 1975-12-30 Process of improving the compatibility of gamma globulins Expired CA1058075A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (1)

Publication Number Publication Date
CA1058075A true CA1058075A (en) 1979-07-10

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
CA242,734A Expired CA1058075A (en) 1975-01-02 1975-12-30 Process of improving the compatibility of gamma globulins

Country Status (20)

Country Link
JP (1) JPS5512001B2 (pt)
AT (1) AT344883B (pt)
AU (1) AU505416B2 (pt)
BE (1) BE837211A (pt)
CA (1) CA1058075A (pt)
DD (1) DD121875A5 (pt)
DE (1) DE2500076C3 (pt)
DK (1) DK144679C (pt)
EG (1) EG11987A (pt)
ES (1) ES443982A1 (pt)
FR (1) FR2296429A1 (pt)
GB (1) GB1495159A (pt)
IE (1) IE43449B1 (pt)
IL (1) IL48766A (pt)
IN (1) IN143525B (pt)
NL (1) NL179824C (pt)
PL (1) PL99599B1 (pt)
SE (1) SE437470B (pt)
SU (1) SU576898A3 (pt)
ZA (1) ZA758050B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
PT1954718E (pt) 2005-11-30 2014-12-16 Abbvie Inc Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos
DK1976877T4 (en) 2005-11-30 2017-01-16 Abbvie Inc Monoclonal antibodies to amyloid beta protein and uses thereof
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
MX360403B (es) 2010-04-15 2018-10-31 Abbvie Inc Proteinas de union a amiloide beta.
EP2603524A1 (en) 2010-08-14 2013-06-19 AbbVie Inc. Amyloid-beta binding proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (pt) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
ZA738779B (en) * 1972-11-27 1974-10-30 Baxter Laboratories Inc Production of gamma globulin
JPS49101516A (pt) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
JPS5191321A (en) 1976-08-10
PL99599B1 (pl) 1978-07-31
ATA981675A (de) 1977-12-15
SU576898A3 (ru) 1977-10-15
DE2500076A1 (de) 1976-07-08
GB1495159A (en) 1977-12-14
ZA758050B (en) 1976-12-29
EG11987A (en) 1981-12-31
DD121875A5 (pt) 1976-09-05
IL48766A (en) 1979-11-30
NL7514627A (nl) 1976-07-06
DE2500076B2 (de) 1979-02-22
SE7514388L (sv) 1976-07-05
ES443982A1 (es) 1977-07-16
FR2296429B1 (pt) 1978-12-01
AT344883B (de) 1978-08-10
DK144679C (da) 1982-10-11
IE43449B1 (en) 1981-02-25
FR2296429A1 (fr) 1976-07-30
SE437470B (sv) 1985-03-04
BE837211A (fr) 1976-06-30
JPS5512001B2 (en) 1980-03-29
IE43449L (en) 1976-07-02
NL179824B (nl) 1986-06-16
IL48766A0 (en) 1976-02-29
IN143525B (pt) 1977-12-17
NL179824C (nl) 1986-11-17
DE2500076C3 (de) 1982-11-18
DK584375A (da) 1976-07-03
AU505416B2 (en) 1979-11-22
DK144679B (da) 1982-05-10
AU8792175A (en) 1977-07-14

Similar Documents

Publication Publication Date Title
CA1058075A (en) Process of improving the compatibility of gamma globulins
CA1074698A (en) Method of collecting anti-hemophilic factor viii from blood and blood plasma
US5177194A (en) Process for purifying immune serum globulins
US4216205A (en) Process of preparing a serum protein composition for intravenous application
US4069216A (en) Simplified methods for preparation of very high purity Factor VIII concentrate
US4075193A (en) Process for producing intravenous immune globulin
CN105153297B (zh) 一种从Cohn组分Ⅳ沉淀中分离纯化α2-巨球蛋白的方法
EP0011032B1 (en) Method for isolation of hbsag
US4764279A (en) Process for preparing the principal proteins of hemolyzed blood in the non-denatured form
US4164495A (en) Method of recovering immunoglobulin using a polyol and an alkanoic acid
KR960001473B1 (ko) 정맥 주사용 면역글로불린 제제의 제조 방법
CA1323139C (en) Method of producing substantially pure albumin
SK54993A3 (en) Imidoester cross-linked hemoglobin compositions
US4322403A (en) Method for the preparation of an immune globulin solution suitable for intravenous use
Zittle et al. Purification of human red cell acetylcholinesterase
US2793203A (en) Process of preparing stable, highly purified gamma globulin preparations
USRE31268E (en) Method of recovering immunoglobulin using a polyol and an alkanoic acid
EP0138167A1 (en) Method for purification of HBs antigen
JPS62503036A (ja) 静脈を介して投与されるガンマ−グロブリンの調製方法および該方法により得られたガンマ−グロブリン
US4745053A (en) Process for producing human interferon and method for assaying the interferon productivity of blood
US4197238A (en) Method of preparation of human albumin using polyethylene glycol
Masri et al. Studies on abnormal hemoglobins. XII. Terminal and free amino groups of various types of human hemoglobin
CN114805504A (zh) 一种低聚合破伤风类毒素制备方法
FR2473886A1 (fr) Perfectionnement aux procedes de concentration et de purification du facteur anti-hemophilique (facteur viii) et preparations de facteur viii concentre et purifie obtenues
US2123198A (en) Treatment of antitoxins and the like